Recent News

• 11.18.2025 - TFF-β suppresses the activity of multiple immune cell types while inducing immunosuppressive cell phenotypes.
• 11.18.2025 - TFF-β suppresses the activity of multiple immune cell types while inducing immunosuppressive cell phenotypes.
• 11.18.2025 - TFF-β suppresses the activity of multiple immune cell types while inducing immunosuppressive cell phenotypes.
• 11.18.2025 - TFF-β suppresses the activity of multiple immune cell types while inducing immunosuppressive cell phenotypes.
• 11.18.2025 - TFF-β suppresses the activity of multiple immune cell types while inducing immunosuppressive cell phenotypes.
• 11.18.2025 - TFF-β suppresses the activity of multiple immune cell types while inducing immunosuppressive cell phenotypes.
• 11.12.2025 - Cue Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
• 11.06.2025 - Cue Biopharma and ImmunoScape Announce Strategic Collaboration to Develop Breakthrough Cell Therapy Approach for Solid Tumors
• 11.02.2025 - Cytokines (ICIS) Annual Meeting
• 09.29.2025 - Colin Sandercock, M.S.E., J.D.

Recent Filings

• 11.12.2025 - 8-K Current report
• 11.12.2025 - EX-99.1 EX-99.1
• 11.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.06.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 8-K Current report
• 10.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.02.2025 - 3 Initial statement of beneficial ownership of securities